Risklick joins Debiopharm Innovation Fund Portfolio
BC Platforms and NTT Group announce exclusive collaboration
New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients
Nucleai and GoPath Diagnostics announce strategic collaboration
SIFTED – Clinical trials need a revamp — could Europe lead the charge?
Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment
Carevive partners with Canopy Cancer Collective
Mika selected for White House initiative
Iktos and Elsevier announce their partnership
